Safi R. Bahcall
2011
In 2011, Safi R. Bahcall earned a total compensation of $1.6M as Former President and Chief Executive Officer at Synta Pharmaceuticals, a 31% increase compared to previous year.
Compensation breakdown
| Bonus | $193,500 |
|---|---|
| Option Awards | $850,000 |
| Salary | $425,833 |
| Stock Awards | $60,748 |
| Other | $80,549 |
| Total | $1,610,630 |
Bahcall received $850K in option awards, accounting for 53% of the total pay in 2011.
Bahcall also received $193.5K in bonus, $425.8K in salary, $60.7K in stock awards and $80.5K in other compensation.
Rankings
In 2011, Safi R. Bahcall's compensation ranked 3,980th out of 10,747 executives tracked by ExecPay. In other words, Bahcall earned more than 63.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,980 out of 10,747 | 63rd |
Division Manufacturing | 1,403 out of 3,960 | 65th |
Major group Chemicals And Allied Products | 284 out of 1,038 | 73rd |
Industry group Drugs | 163 out of 786 | 79th |
Industry Pharmaceutical Preparations | 133 out of 571 | 77th |
Source: SEC filing on April 30, 2014.
Bahcall's colleagues
We found four more compensation records of executives who worked with Safi R. Bahcall at Synta Pharmaceuticals in 2011.
2011
Vojo Vukovic
Synta Pharmaceuticals
Chief Medical Officer
2011
Keizo Koya
Synta Pharmaceuticals
Senior Vice President, Drug Development
2011
Keith Ehrlich
Synta Pharmaceuticals
Chief Financial Officer
2011
Amar Singh
Synta Pharmaceuticals